A new study concludes that taking the drug modafinil, typically used to treat sleep disorders, in combination with antidepressants reduces the severity of depression more effectively than taking antidepressants alone. Approximately a third of depressed patients receive little or no benefit from taking antidepressants. Those who do respond to treatment can suffer residual symptoms such […]
National Institute for Health Research partnership to revolutionise brain injury care
The NIHR Cambridge Healthcare Technology Co-operative (HTC) for Brain Injury was officially launched earlier this month, bringing together patients, carers, inventors, industry, academics and charities. The Brain Injury HTC works co-operatively and collaboratively to identify areas of unmet need and develop novel technology-based solutions for patients at every stage after brain injury. The HTC is […]
Message from the Regius – December 2013
Recently we received the welcome news that Cambridge University Health Partners has been redesignated as an Academic Health Science Centre from 2014. In the original process we were one of only five AHSC’s designated from 2009 – 2014. The other four AHSC’s in the initial competition were UCL, Imperial, King’s and Manchester. This time round […]
Message from the Regius
I attended the annual Cancer Centre symposium last week which included excellent talks from scientists in the Clinical School, from Biochemistry, and also from the Babraham and Sanger Institutes. The Cancer Centre has a compelling vision, which is to harness Cambridge Science in order to change the way we treat cancer. We heard the excellent […]
Breakthrough for spinal cord injury research
A team from the Department of Neurosciences have created a device that could one day restore bladder function to patients with a severed spinal cord. Researchers have discovered that electrodes wrapped around bundles of nerves can interpret signals that say the bladder is full. The device has worked on rats, and the challenge now is […]
Cancer Research UK honours two Cambridge researchers
Professor Sir Bruce Ponder, Department of Oncology has been presented with a prestigious Lifetime Achievement Award by Cancer Research UK. The award recognises his contribution to the identification and understanding of genetic susceptibility to breast cancer and other common cancers, as well as his achievements in building cancer research in Cambridge into a world-renowned centre […]
Link between ACE inhibitors and acute kidney injury
ACE inhibitors and related drugs known as angiotensin receptor antagonists (ARAs) are among the most frequently prescribed medicines in UK clinical practice, used to treat conditions such as high blood pressure, heart disease and kidney problems. There have been concerns about a link between these drugs and kidney function but for the first time researchers […]
Athena SWAN Awards Ceremony
Dr Eleanor Bolton, Department of Surgery, attended the Athena SWAN Awards Ceremony in London earlier this month to collect the Silver award on behalf of the School. Dr Bolton, who was part of the team responsible for compiling the successful submission, was presented with the award by Professor Dame Julia Higgins, Emeritus Professor of Polymer Science […]
New urine test to identify type 1 diabetes risks
Up to 40 per cent of young people with type 1 diabetes may go on to develop heart and kidney disease. Now, thanks to research funded by the Juvenile Diabetes Research Foundation Ltd (JRDF), Diabetes UK, and the British Heart Foundation (BHF), simple urine tests could identify those at risk. In the first study of […]
- « Previous Page
- 1
- …
- 9
- 10
- 11
